The Potential of S100 Calcium-Binding Protein B and Glial Fibrillary Acid Protein in Predicting the Intracranial Lesions in Mild Traumatic Brain Injury: A Systematic Review of Literature

Andre Marolop Pangihutan Siahaan; Eric Teo Fernando

doi:10.3889/oamjms.2022.9566

Authors

Andre Marolop Pangihutan Siahaan Department of Neurosurgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Eric Teo Fernando Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia https://orcid.org/0000-0002-6903-5805

DOI:

https://doi.org/10.3889/oamjms.2022.9566

Keywords:

Glial fibrillary acid protein, Mild traumatic brain injury, S100 calcium-binding protein B

Abstract

ABSTRACT

AIM: To summarize the current evidence of S100B and GFAP in predicting intracranial lesions after mTBI.

MATERIAL AND METHODS: We searched publications on biomarkers in mTBI from Web of Science, PubMed, and Scopus between January 1990 and July 2021. We included RCTs, cohort, case control, and cross-sectional studies that involved patients with acute closed mTBI in all age group in which head CT scan and blood-based biomarkers (GFAP and S100B) examination were conducted under 24 hours. This study was registered in Open Science Framework.

RESULTS: The initial search identified 4.937 article, in which 127 were included for full-text assessment. A total of 16 articles were finally included. No RCT was found in literature searching. Thirteen studies were studying S100B and three studies were studying GFAP. Nine out of 13 S100B studies shows a promising result with ≥ 95% sensitivity for detecting intracranial lesions. Majorities (11 /13) studies of S100B confirmed that S100B reduced the unnecessary usage of CT scan. GFAP concentration significantly increased in CT+ patient than CT- patient. No specific GFAP cut off value between the studies was found.

CONCLUSION: The result showed that S100B and GFAP had potential to predict the occurrence of intracranial lesions. Variance between methodologies and cut off value hindered the quality of evidence, especially in GFAP.

KEYWORDS: mild traumatic brain injury, S100B, GFAP.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2019;130(4):1080-97. https://doi.org/10.3171/2017.10.jns17352 PMid:29701556 DOI: https://doi.org/10.3171/2017.10.JNS17352

Ganti L, Stead T, Daneshvar Y, Bodhit AN, Pulvino C, Ayala SW, et al. GCS 15: When mild TBI isn’t so mild. Neurol Res Pract. 2019;1(1):1-8. https://doi.org/10.1186/s42466-018-0001-1 PMid:33324872 DOI: https://doi.org/10.1186/s42466-018-0001-1

Jagoda AS, Bazarian JJ, Bruns JJ, Cantrill S V., Gean AD, Howard PK, et al. Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med. 2008;52(6):714-48. https://doi.org/10.1016/j.annemergmed.2008.08.021 PMid:19027497 DOI: https://doi.org/10.1016/j.annemergmed.2008.08.021

Smith-Bindman R. Is computed tomography safe? N Engl J Med. 2010;363(1):1-4. https://doi.org/10.1056/NEJMp1002530 PMid:20573919 DOI: https://doi.org/10.1056/NEJMp1002530

Abalo KD, Rage E, Leuraud K, Richardson DB, Le Pointe HD, Laurier D, et al. Early life ionizing radiation exposure and cancer risks: Systematic review and meta-analysis. Pediatr Radiol. 2021;51(1):45-56. https://doi.org/10.1007/s00247-020-04803-0 PMid:32910229 DOI: https://doi.org/10.1007/s00247-020-04803-0

Meulepas JM, Ronckers CM, Smets AM, Nievelstein RA, Gradowska P, Lee C, et al. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst. 2019;111(3):256-63. https://doi.org/10.1093/jnci/djy104 PMid:30020493 DOI: https://doi.org/10.1093/jnci/djy104

Heidari K, Vafaee A, Rastekenari AM, Taghizadeh M, Shad EG, Eley R, et al. S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: Systematic review and meta-analysis. Brain Inj. 2015;29(10):1146-57. https://doi.org/10.3109/02699052.2015.1037349 PMid:26067622 DOI: https://doi.org/10.3109/02699052.2015.1037349

Luoto TM, Raj R, Posti JP, Gardner AJ, Panenka WJ, Iverson GL. A systematic review of the usefulness of glial fibrillary acidic protein for predicting acute intracranial lesions following head trauma. Front Neurol. 2017;8:652. https://doi.org/10.3389/fneur.2017.00652 PMid:29255443 DOI: https://doi.org/10.3389/fneur.2017.00652

Manivannan S, Makwana M, Ahmed AI, Zaben M. Profiling biomarkers of traumatic axonal injury: From mouse to man. Clin Neurol Neurosurg. 2018;171:6-20. https://doi.org/10.1016/j.clineuro.2018.05.017 PMid:29803093 DOI: https://doi.org/10.1016/j.clineuro.2018.05.017

Hier DB, Obafemi-Ajayi T, Thimgan MS, Olbricht GR, Azizi S, Allen B, et al. Blood biomarkers for mild traumatic brain injury: A selective review of unresolved issues. Biomark Res 2021;9(1):70. https://doi.org/10.1186/s40364-021-00325-5 PMid:34530937 DOI: https://doi.org/10.1186/s40364-021-00325-5

Wu Y, Wu H, Guo X, Pluimer B, Zhao Z. Blood-Brain barrier dysfunction in mild traumatic brain injury: Evidence from preclinical murine models. Front Physiol. 2020;11:1030. https://doi.org/10.3389/fphys.2020.01030 PMid:32973558 DOI: https://doi.org/10.3389/fphys.2020.01030

Turtzo L, Jikaria N, Cota M, Williford JP, Uche V, Davis T, et al. Meningeal blood–brain barrier disruption in acute traumatic brain injury. Brain Commun. 2020;2(2):fcaa143. https://doi.org/10.1093/braincomms/fcaa143 PMid:33829156 DOI: https://doi.org/10.1093/braincomms/fcaa143

Plog BA, Dashnaw ML, Hitomi E, Peng W, Liao Y, Lou N, et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci. 2015;35(2):518-26. https://doi.org/10.1523/jneurosci.3742-14.2015 PMid:25589747 DOI: https://doi.org/10.1523/JNEUROSCI.3742-14.2015

Bacyinski A, Xu M, Wang W, Hu J. The paravascular pathway for brain waste clearance: Current understanding, significance and controversy. Front Neuroanat. 2017;11:101. https://doi.org/10.3389/fnana.2017.00101 PMid:29163074 DOI: https://doi.org/10.3389/fnana.2017.00101

Posti JP, Takala RS, Runtti H, Newcombe VF, Outtrim J, Katila AJ, et al. The levels of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 during the first week after a traumatic brain injury: Correlations with clinical and imaging findings. Neurosurgery. 2016;79(3):456-64. https://doi.org/10.1227/neu.0000000000001226 PMid:26963330 DOI: https://doi.org/10.1227/NEU.0000000000001226

Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: Relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31(1):19-25. https://doi.org/10.1016/b978-0-12-816346-7.00012-9 PMid:23865516 DOI: https://doi.org/10.1089/neu.2013.3040

Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73(5):551-60. https://doi.org/10.1001/jamaneurol.2016.0039 PMid:27018834 DOI: https://doi.org/10.1001/jamaneurol.2016.0039

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ. 2009;339:b2700. https://doi.org/10.1136/bmj.b2700 PMid:19622552 DOI: https://doi.org/10.1136/bmj.b2700

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Ottawa Hospital Research Institute; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. [Last accessed on 2022 Jan 07].

RoB 2: A revised Cochrane Risk-of-Bias Tool for Randomized Trials | Cochrane Bias; 2018. Available from: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. [Last accessed on 2022 Jan 07].

Mozafari J, Fahimi MA, Mohammadi K, Barzegari H, Hanafi MG, Saki-Malehi A. The diagnostic accuracy of serum and urinary S100B protein in children and adolescents with mild traumatic brain injury. New Zeal J Med Lab Sci. 2019;73(3):88-91.

Kelmendi FM, Morina AA, Mekaj AY, Blyta A, Alimehmeti R, Dragusha S, et al. Serum S100B levels can predict computed tomography findings in paediatric patients with mild head injury. Biomed Res Int. 2018;2018:6954045. https://doi.org/10.1155/2018/6954045 PMid:29850551 DOI: https://doi.org/10.1155/2018/6954045

Manzano S, Holzinger IB, Kellenberger CJ, Lacroix L, Klima-Lange D, Hersberger M, et al. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma. Emerg Med J. 2016;33(1):42-6. https://doi.org/10.1136/emermed-2014-204513 PMid:26283067 DOI: https://doi.org/10.1136/emermed-2014-204513

Bouvier D, Fournier M, Dauphin J-BB, Amat F, Ughetto S, Labbé A, et al. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clin Chem. 2012;58(7):1116-22. https://doi.org/10.1373/clinchem.2011.180828 PMid:22529109 DOI: https://doi.org/10.1373/clinchem.2011.180828

Blais Lécuyer J, Mercier É, Tardif PA, Archambault PM, Chauny JM, Berthelot S, et al. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: A subanalysis of a prospective cohort study. Emerg Med J. 2021;38:285-9. https://doi.org/10.1136/emermed-2020-209583 PMid:33355233 DOI: https://doi.org/10.1136/emermed-2020-209583

Seidenfaden SC, Kjerulff JL, Juul N, Kirkegaard H, Møller MF, Münster AM, et al. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: A prospective observational multicenter cohort study – “The PreTBI I study.” Scand J Trauma Resusc Emerg Med. 2021;29(1):75. https://doi.org/10.1186/s13049-021-00891-5 PMid:34078435 DOI: https://doi.org/10.1186/s13049-021-00891-5

Kahouadji S, Salamin P, Praz L, Coiffier J, Frochaux V, Durif J, et al. S100B blood level determination for early management of ski-related mild traumatic brain injury: A pilot study. Front Neurol. 2020;11:856. https://doi.org/10.3389/fneur.2020.00856 PMid:32922357 DOI: https://doi.org/10.3389/fneur.2020.00856

David A, Mari C, Vignaud F, Masson D, Planche L, Bord E, et al. Evaluation of S100B blood level as a biomarker to avoid computed tomography in patients with mild head trauma under antithrombotic medication. Diagn Interv Imaging. 2017;98(7-8):551-6. https://doi.org/10.1016/j.diii.2017.03.010 PMid:28579521 DOI: https://doi.org/10.1016/j.diii.2017.03.010

Lewis LM, Schloemann DT, Papa L, Fucetola RP, Bazarian J, Lindburg M, et al. Utility of serum biomarkers in the diagnosis and stratification of mild traumatic brain injury. Acad Emerg Med. 2017;24(6):710-20. https://doi.org/10.1111/acem.13174 PMid:28170122 DOI: https://doi.org/10.1111/acem.13174

Lagerstedt L, José Egea-Guerrero J, Bustamante A, Montaner J, Rodríguez-Rodríguez A, El Rahal A, et al. H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury. PLoS One. 2017;12(4):e0175572. https://doi.org/10.1371/journal.pone.0175572 PMid:28419114 DOI: https://doi.org/10.1371/journal.pone.0175572

Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, et al. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury a prospective multicenter study. Shock. 2006;25(5):446-53. https://doi.org/10.1097/01.shk.0000209534.61058.35 PMid:16680008 DOI: https://doi.org/10.1097/01.shk.0000209534.61058.35

Poli-de-Figueiredo LF, Biberthaler P, Simao Filho C, Hauser C, Mutschler W, Jochum M. Measurement of S-100B for risk classification of victims sustaining minor head injury - First pilot study in Brazil. Clinics. 2006;61(1):41-6. https://doi.org/10.1590/s1807-59322006000100008 PMid:16532224 DOI: https://doi.org/10.1590/S1807-59322006000100008

Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock. 2002;18(5):395-400. https://doi.org/10.1097/00024382-200211000-00002 PMid:12412616 DOI: https://doi.org/10.1097/00024382-200211000-00002

Forouzan A, Barzegari H, Hosseini O, Delirrooyfard A. The diagnostic competence of glial fibrillary acidic protein in mild traumatic brain injury and its prognostic value in patient recovery. Turk Neurosurg. 2021;31(3):355-60. https://doi.org/10.5137/1019-5149.jtn.31021-20.2 PMid:33978198 DOI: https://doi.org/10.5137/1019-5149.JTN.31021-20.2